Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
Stories in the Clouds partners science and curious facts with folklore and the legends early cultures told to explain weather. The Thunder God, Father Frost, Spider Weaver, and others appear in tales from China, Russia, Japan, indigenous peoples, and other cultures. Detailed sidebars explain the seasons, Earth’s atmosphere, and meteorology. Find out more at http://www.joangalat.com Genre- children, science
A Princess of Roumania fantasy, with an extraordinary, intense, compressed SF novel in three parts, each set in its own alternate-history universe. The sections are all rooted in Virginia and the Battle of the Crater, and are also grounded in the real history of the Park family, from differing points of view.
The first section is set in the aftermath of the Civil War, in a world in which the Queen of the North has negotiated a two-nation settlement. The second, taking place in northwestern Massachusetts, investigates a secret project during World War II, in a time somewhat like the present. The third is set in the near-future United States, with aliens from history.
The cumulative effect is awesome. There hasn’t been a three part novel this ambitious in science fiction since Gene Wolfe’s classic The Fifth Head of Cerberus. Find out more at http://us.macmillan.com/allthosevanishedengines/PaulPark Fantasy/Scifi
High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65964-ccfa-genetic-microbiome-discoveries-ibd-crohn-s-disease-ulcerative-colitis
For the first time a YSL skincare product joins the collection at a science museum. Glycobiology, the science of glycans applied to the skin and cosmetics pioneered by YSL Beauté with FOREVER YOUTH LIBERATOR SERUM, is now part of the Berlin Museum‘s newly inaugurated permanent exhibition dedicated to the central role played by glycans in the realm of life.
After being closed for renovations for three years, the Berlin-based Sugar Museum has reopened as part of the Deutsches Technikmuseum with an expanded exhibition about sugars: “Sugars and Beyond! Food – Matter – Energy”, from November 26, 2015. In addition to the traditional focus of the former Sugar Museum, which concentrated on the production, use and social history of cane and beet sugars, the newly opened exhibition sheds light on the topic of sugar from entirely new perspectives.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7709551-ysl-beaute-forever-youth-liberator-serum/
The Verizon Innovative App Challenge - the no-coding-skills-needed contest that gives middle and high school students a chance to bring their problem-solving app ideas to life - is back! In its fourth year, the App Challenge calls students to gather teams, dream up ideas, and create concepts for mobile apps that could solve problems in their schools and communities.
For the first time, the App Challenge will be open to teams representing non-profit organizations in addition to schools, and even more students will earn free tablets and cash awards for the groups they represent. The deadline for submission is Nov. 24, and the winners will be named in January 2016.
Bill Nye, the Science Guy, is helping Verizon to encourage students nationwide to submit their ideas and to organize their teams now.
Created by the Verizon Foundation in partnership with the Technology Student Association, the App Challenge offers hands-on, experiential learning to ultimately help students envision brighter futures for themselves that they may never have imagined, as business owners, app inventors and professional coders.
To view the multimedia release visit:
http://www.multivu.com/players/English/7593951-verizon-innovative-app-challenge/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr on receiving the 2015 Institut de France’s Grand Prix Scientifique in a Paris awards ceremony.
The Grand Prix is one of the largest prizes for scientific accomplishment and is considered the world’s most prestigious prize for cardiovascular research. The Institut’s board awarded Starr the Grand Prix in recognition of research that led to the world’s first successful artificial mitral valve implant in 1960. In the last 55 years, millions of patients around the world have benefitted from the emergence of the field of heart valve replacement and the many technological advances that followed.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7536851-france-grand-prix-starr-edwards/
The Ball Aerospace & Technologies Corp. Ralph camera aboard the New Horizons mission will provide the closest images we have ever seen of Pluto when the spacecraft arrives at the dwarf planet on July 14.
Ralph, the main “eyes” of New Horizon is designed to help scientists map the surface geology of Pluto and its moons, and investigate Kuiper Belt objects. The small but powerful Ralph weighs only 23 pounds and operates on approximately seven watts, the power of a standard night light. The entire telescope operates around 220 K (-60°F) in the cold darkness of the outer solar system. After a journey of more than nine years, Ralph will capture the first ever close-up snapshots of Pluto when New Horizons passes within 7,000 miles of the tiny, icy dwarf planet.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7530151-ball-aerospace-new-horizons-mission-pluto/
The Astana Economic Forum is an annual event held in Astana, the capital of the Republic of Kazakhstan, which brings together representatives from the world’s economic community, current and former heads of states, Nobel Prize laureates, outstanding figures from the scientific world, and businessmen. The Forum is best known as a platform for international dialogue that enables constructive discussion of economic development issues concerning both Central Asia and the entire world in relation to changes witnessed in the global economy.
This year the Astana Economic Forum 2016 was held on May 25-26 in Astana, Kazakhstan under the theme “New economic reality: diversification, innovation and knowledge economy”. The agenda of the Forum traditionally included the most topical issues on economic development.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7872751-recommendations-astana-economic-forum/
In conjunction today with Thomas Edison’s birthday and National Inventors Day, the National Inventors Hall of Fame®, in partnership with the United States Patent and Trademark Office (USPTO), announces it will induct 19 innovation pioneers for their world-changing inventions on May 1-2 during the Greatest Celebration of American Innovation®.
To view the multimedia release go to:
https://www.multivu.com/players/English/8434551-national-inventors-hall-of-fame-2019-inductees/
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
It is estimated that almost 40 percent of men and women in the U.S. will be diagnosed with cancer sometime during their lifetime. Kommah, who was diagnosed at age 29, now has her health and her son, thanks to discoveries made at City of Hope, where scientists and doctors turn laboratory breakthroughs into treatments that defeat cancer.
Today, the nonprofit research and comprehensive cancer center near Los Angeles is rolling out a new initiative that builds on its legacy of discovery to let people know that City of Hope not only offers a uniquely patient-centric, integrated approach to care, but also with the help of donors and volunteers, it is pursuing research that will change the future of medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7665051-city-of-hope-miracle-science-soul-campaign/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
